Schubert & Co’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17
Closed -$620 1576
2023
Q1
$620 Buy
17
+8
+89% +$280 ﹤0.01% 1358
2022
Q4
$266 Sell
9
-7
-44% -$225 ﹤0.01% 1497
2022
Q3
$1K Buy
16
+4
+33% +$183 ﹤0.01% 1322
2022
Q2
$0 Buy
12
+10
+500% +$380 ﹤0.01% 1620
2022
Q1
$0 Sell
2
-2
-50% -$103 ﹤0.01% 1380
2021
Q4
$0 Buy
+4
New +$329 ﹤0.01% 1326

Other funds holding ASTH

Schubert & Co's ASTH Position: Q2 2023 in Review

Schubert & Co sold out of Astrana Health (ASTH) in Q2 2023, closing a stake of 17 shares — an estimated $620 sold.

Schubert & Co first reported a position in ASTH in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 130 funds tracked by Wall St. Rank hold ASTH as of Q2 2023.

  • Schubert & Co reported no remaining Astrana Health position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 17 Astrana Health shares in Q2 2023, an estimated $620.
  • Schubert & Co first reported a position in Astrana Health in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Astrana Health position peaked at $1K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.